HTB | HIV i-Base

Global update: 90-day review ended early and cancelled 10,000 grants, millions of people will suffer

Featured Reduced dosing: a possible crisis response to ART stockouts and closed clinics 5 May 2025. Related: Special reports, Antiretrovirals, Treatment strategies, Treatment access.
IAS-USA update in drug resistance mutations (2025) 29 May 2025. Related: Early access, Drug resistance.
Vaccination is effective in limiting mpox progression – but lower efficacy in people living with HIV 27 May 2025. Related: Journal scan, Early access, mpox.
US update guidelines for statin use in people living with HIV 26 May 2025. Related: Early access, Guidelines, Weight, diabetes, metabolic complications.
HIV activists in the US call for action in JID and Zachie Achmat brings South African perspective in the Lancet 26 May 2025. Related: Journal scan, Early access, Treatment advocacy.
Combining injectable lenacapavir and cabotegravir-LA 23 May 2025. Related: Journal scan, Antiretrovirals, Treatment strategies, Treatment access.
Scientific, legal and ethical crisis from halting ongoing NIH studies: TAG statement 22 May 2025. Related: Early access, Special reports, Treatment access, Women's health, Paediatric care, Cure-related research, Research studies.
Impact of US funding cuts in Malawi and South Africa: ITPC community report 20 May 2025. Related: Journal scan, Treatment access.
The Denver Principles – riso print by Jane Shepherd to support i-Base 17 May 2025. Related: Special reports.
US CDC updated guidelines on PEP (May 2025) 10 May 2025. Related: Early access, Guidelines, HIV prevention and transmission.
Closed clinics and limited ART in Zimbabwe, PEPFAR and UNAIDS news 4 May 2025. Related: Early access, Treatment access.
Future meetings and webinars 2025 1 May 2025. Related: Future meetings.
Yellow card reporting scheme for doctors and patients in the UK 1 May 2025. Related: Side effects.
The RIO study: Q&A about controlling HIV with bNAbs 21 April 2025. Related: Early access, Conference reports, Cure-related research, CROI 32 San Francisco 2025.
Lenacapavir EAP in the UK closed to new referrals: NHS England and Gilead fail to agree a price after more than two years 20 April 2025. Related: Early access, Antiretrovirals, Treatment access, Drug resistance, BHIVA news.
CROI 2025: Webcasts and other resources now open access 16 April 2025. Related: Conference reports, CROI 32 San Francisco 2025.
Continued reports from CROI 2025 13 April 2025. Related: Conference reports, Conference index, CROI 32 San Francisco 2025.
Viral failure on CAB/RPV-LA: overcoming drug resistance with second-generation INSTIs 13 April 2025. Related: Journal scan, Early access, Treatment strategies, Drug resistance.
CROI 2025: LAPTOP, EC rebounds after 32 years, two more HSCT cures 12 April 2025. Related: Conference reports, Antiretrovirals, Treatment strategies, CROI 32 San Francisco 2025.
Lancet Commission on gender justice and equality 9 April 2025. Related: Journal scan.
Changes to US policy jeopardises the lives of 500,000 children living with HIV by 2030 8 April 2025. Related: Treatment access.
CROI 2025: Rebecca Denison gives opening community talk on 40 years of HIV 7 April 2025. Related: Conference reports, Treatment advocacy, CROI 32 San Francisco 2025.
Lancet HIV recognises Transgender Day of Visibility and the importance of gender-affirming hormones in HIV care 3 April 2025. Related: Journal scan, Early access, Special reports, Treatment access.
CROI 2025: BHIVA best of CROI feedback now online 1 April 2025. Related: Conference reports, On the web, CROI 32 San Francisco 2025.
People living with HIV need two shots of the mpox vaccine and likely a booster after two years 1 April 2025. Related: Journal scan, mpox.
CROI 2025: Two bNAbs enable viral suppression off-ART in African women in the FRESH cohort 1 April 2025. Related: Conference reports, Cure-related research, CROI 32 San Francisco 2025.
Cuts in aid: up to 10 million new HIV infections and almost 3 million related deaths by 2030 28 March 2025. Related: Journal scan, Treatment access.
Stopping ART safely if your clinic is closed or runs out of meds: a practical guide 25 March 2025. Related: Special reports, Treatment strategies.
Webinar on stopping ART if your clinic is closed: practical facts on safety and risk 24 March 2025. Related: Special reports, Treatment strategies, Treatment access, On the web.
CROI 2025: Introduction to this year’s conference 22 March 2025. Related: Conference reports, Conference index, CROI 32 San Francisco 2025.
CROI 2025: RIO study: Dual-bNABs keep viral load undetectable off-ART – plus a potential first case of vaccine-like HIV remission 21 March 2025. Related: Conference reports, Cure-related research, CROI 32 San Francisco 2025.
CROI 2025: Switching to daily fixed-dose doravirine/islatravir: two randomised phase 3 studies 20 March 2025. Related: Conference reports, Antiretrovirals, CROI 32 San Francisco 2025.
CROI 2025: Tecovirimat has no benefit against mpox in STOMP study 18 March 2025. Related: Conference reports, mpox, CROI 32 San Francisco 2025.
CROI 2025: Ensitrelvir significantly reduces risk of developing COVID-19 after household exposure 18 March 2025. Related: Conference reports, COVID-19, CROI 32 San Francisco 2025.
CROI 2025: N6LS: 4-monthly injectable bNAb with monthly injectable cabotegravir 18 March 2025. Related: Conference reports, Antiretrovirals, CROI 32 San Francisco 2025.
Summary of Australian guidelines for anal cancer screening in people living with HIV 18 March 2025. Related: Guidelines.
CROI 2025: Reducing Biktarvy from daily to only once, twice or three times a week 17 March 2025. Related: Conference reports, Antiretrovirals, Treatment strategies, CROI 32 San Francisco 2025.
CROI 2025: Potential for once-yearly lenacapavir injections 16 March 2025. Related: Conference reports, Antiretrovirals, PK and drug interactions, HIV prevention and transmission, CROI 32 San Francisco 2025.
CROI 2025: Delegates send open letter to protest US cuts 12 March 2025. Related: Conference reports, Treatment advocacy, CROI 32 San Francisco 2025.
CROI 2025: Stand Up For Science rally against Trump funding freeze 9 March 2025. Related: Conference reports, Treatment advocacy, CROI 32 San Francisco 2025.
HIV and vaccine denialist is proposed to head the US NIH: further alarm for global science 7 March 2025. Related: Treatment advocacy.
Global update: 90-day review ended early and cancelled 10,000 grants, millions of people will suffer 1 March 2025. Related: Special reports, Treatment access.
Responses to the UK government slashing international aid by 40% 26 February 2025. Related: Treatment access, Treatment advocacy.
Deleted words from official documents: LGBTQ, diversity, inclusion, transgender 26 February 2025. Related: Treatment access, Treatment advocacy.
Country update from Nigeria: current impact on HIV services 22 February 2025. Related: Special reports, Treatment access.
Semaglutide reduces alcohol and cigarette use in a randomised phase 2 study 12 February 2025. Related: Weight, diabetes, metabolic complications, Coinfections and complications.
News and resources linked to changes in US policy on international aid 7 February 2025. Related: Special reports.
Impact of US elections and executive orders on global health: waiver covers PEPFAR with restrictions 7 February 2025. Related: Special reports, Treatment access, Treatment advocacy.
IAS public letter: Why HIV could be poised for a monumental comeback 6 February 2025. Related: Treatment access, On the web.
Lenacapavir for PrEP submitted to EMA for EU and global use 4 February 2025. Related: Antiretrovirals, HIV prevention and transmission.